Levofloxacin Fresenius Kabi

Levofloxacin, the active ingredient in Levofloxacin Fresenius Kabi, is a fluoroquinolone presented as an intravenous solution for intravenous use. It is employed to treat a range of susceptible bacterial infections in adult patients, including respiratory, urinary and skin‑soft‑tissue infections.

GNH USA supplies Levofloxacin Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing consistent quality and regulatory compliance.

Levofloxacin is a fluoroquinolone antibacterial used to manage infections caused by susceptible bacteria.

- Community‑Acquired Pneumonia: achieves clinical cure and bacterial eradication in lung infections. - Hospital‑Acquired Pneumonia: effective against multidrug‑resistant respiratory pathogens. - Complicated Urinary Tract Infection: clears infection in kidneys and bladder. - Complicated Skin and Soft Tissue Infection: resolves cellulitis and wound infections. - Intra‑Abdominal Infection: treats peritonitis and intra‑abdominal abscesses.

Levofloxacin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in hepatic markers.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, requiring immediate discontinuation. - QT interval prolongation: may precipitate cardiac arrhythmias. - Clostridioides difficile infection: severe colitis risk. - Anaphylaxis: life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe mucocutaneous eruption. - Hepatic failure: rare but potentially fatal liver injury.

Levofloxacin requires careful patient assessment and monitoring.

- Assess renal function: adjust dosing in patients with impaired clearance. - Monitor for tendon pain: discontinue if signs of tendonitis or rupture appear. - Avoid in patients with known hypersensitivity to fluoroquinolones. - Use caution in individuals with prolonged QT interval or electrolyte disturbances. - Avoid concomitant use with NSAIDs that increase gastrointestinal bleeding risk. - Store at ambient temperature: keep in original container, protect from light and moisture.

Levofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce levofloxacin absorption; separate by at least 2 hours. - Warfarin: may increase INR; close coagulation monitoring required. - Cyclosporine: can raise levofloxacin plasma levels; monitor renal function.

Moderate Interactions (Monitor Closely): - Theophylline: may increase theophylline concentrations; watch for toxicity. - Corticosteroids: heightened risk of tendon rupture; assess musculoskeletal symptoms. - QT‑prolonging agents: additive effect on cardiac rhythm; monitor ECG.